{"id":1301134,"date":"2025-10-07T09:13:24","date_gmt":"2025-10-07T03:43:24","guid":{"rendered":"https:\/\/trak.in\/stories\/?p=1301134"},"modified":"2025-10-07T09:13:57","modified_gmt":"2025-10-07T03:43:57","slug":"pharma-giant-to-invest-rs-8500-crore-in-india-for-making-oral-weight-loss-drug","status":"publish","type":"post","link":"https:\/\/trak.in\/stories\/pharma-giant-to-invest-rs-8500-crore-in-india-for-making-oral-weight-loss-drug\/","title":{"rendered":"Pharma Giant To Invest Rs 8500 Crore In India For Making Oral Weight Loss Drug"},"content":{"rendered":"\n

US pharmaceutical giant Eli Lilly<\/strong> is set to significantly expand its presence in India through a series of strategic initiatives, reinforcing the country as a key hub in its global operations. The company announced plans to invest over $1 billion<\/a><\/strong> in the coming years to bolster contract manufacturing partnerships, enhance global supply chains, and increase access to innovative medicines worldwide.<\/p>\n\n\n\n

\"\"<\/figure>\n\n\n\n

Strategic Investments and Contract Manufacturing<\/h3>\n\n\n\n

Eli Lilly\u2019s investment will focus on contract manufacturing tie-ups<\/strong>, enabling the company to expand production capacity for both current and future medicines. While the company did not disclose specific partners, locations, or products, officials emphasized that these agreements will support treatments for diabetes, obesity, Alzheimer\u2019s, cancer, and autoimmune conditions<\/strong>, as well as prepare for next-generation therapies.<\/p>\n\n\n\n

Patrik Jonsson, EVP and President of Lilly International, said, \u201cThis investment reaffirms our confidence in India as a hub for capability building within our global network.\u201d Since 2020, Lilly has committed over $55 billion globally<\/strong> for facility expansions and acquisitions, and India is now poised to play a central role in this growth trajectory.<\/p>\n\n\n\n

Expanding Weight Loss and Diabetes Portfolio<\/h3>\n\n\n\n

A key focus for Eli Lilly in India is its weight loss and diabetes portfolio<\/strong>. The company is preparing to launch an oral version of its experimental weight-loss drug, orforglipron<\/strong>, following the global success of the injectable Mounjaro (tirzepatide)<\/strong>. India, with an anti-obesity drug market valued at around \u20b9752 crore<\/strong>, is considered a crucial market for the new drug. Regulatory submissions for chronic weight management and obesity are expected by the end of 2025, with approvals likely across multiple countries in the second half of 2026.<\/p>\n\n\n\n

New Manufacturing and Quality Hub in Hyderabad<\/h3>\n\n\n\n

As part of its expansion, Eli Lilly plans to establish a new manufacturing and quality hub in Hyderabad<\/strong>. This center will offer advanced technical capabilities, provide oversight for contract manufacturing partners, and generate new employment opportunities for engineers, chemists, analytical scientists, and quality control professionals.<\/p>\n\n\n\n

The move highlights India\u2019s growing importance in global pharma supply chains<\/strong> and Lilly\u2019s commitment to scaling operations to meet increasing international demand. By leveraging India\u2019s skilled workforce and cost-effective manufacturing capabilities, the company aims to accelerate access to critical medicines while strengthening its global production network.<\/p>\n\n\n\n

Image Source<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"

US pharmaceutical giant Eli Lilly is set to significantly expand its presence in India through a series of strategic initiatives, reinforcing the country as a key hub in its global operations. The company announced plans to invest over $1 billion in the coming years to bolster contract manufacturing partnerships, enhance global supply chains, and increase […]<\/p>\n","protected":false},"author":30,"featured_media":1301142,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_jetpack_memberships_contains_paid_content":false,"footnotes":""},"categories":[21],"tags":[8787,5673],"class_list":["post-1301134","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-business","tag-eli-lilly","tag-weight-loss"],"acf":[],"yoast_head":"\nPharma Giant To Invest Rs 8500 Crore In India For Making Oral Weight Loss Drug - Trak.in - Indian Business of Tech, Mobile & Startups<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/trak.in\/stories\/pharma-giant-to-invest-rs-8500-crore-in-india-for-making-oral-weight-loss-drug\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Pharma Giant To Invest Rs 8500 Crore In India For Making Oral Weight Loss Drug - Trak.in - Indian Business of Tech, Mobile & Startups\" \/>\n<meta property=\"og:description\" content=\"US pharmaceutical giant Eli Lilly is set to significantly expand its presence in India through a series of strategic initiatives, reinforcing the country as a key hub in its global operations. The company announced plans to invest over $1 billion in the coming years to bolster contract manufacturing partnerships, enhance global supply chains, and increase […]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/trak.in\/stories\/pharma-giant-to-invest-rs-8500-crore-in-india-for-making-oral-weight-loss-drug\/\" \/>\n<meta property=\"og:site_name\" content=\"Trak.in - Indian Business of Tech, Mobile & Startups\" \/>\n<meta property=\"article:published_time\" content=\"2025-10-07T03:43:24+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-10-07T03:43:57+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/trak.in\/stories\/wp-content\/uploads\/2025\/10\/Screenshot-2025-10-07-at-9.11.06-AM-1024x612.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1024\" \/>\n\t<meta property=\"og:image:height\" content=\"612\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Mohul Ghosh\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Mohul Ghosh\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"3 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\/\/trak.in\/stories\/pharma-giant-to-invest-rs-8500-crore-in-india-for-making-oral-weight-loss-drug\/\",\"url\":\"https:\/\/trak.in\/stories\/pharma-giant-to-invest-rs-8500-crore-in-india-for-making-oral-weight-loss-drug\/\",\"name\":\"Pharma Giant To Invest Rs 8500 Crore In India For Making Oral Weight Loss Drug - Trak.in - Indian Business of Tech, Mobile & Startups\",\"isPartOf\":{\"@id\":\"https:\/\/trak.in\/stories\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/trak.in\/stories\/pharma-giant-to-invest-rs-8500-crore-in-india-for-making-oral-weight-loss-drug\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/trak.in\/stories\/pharma-giant-to-invest-rs-8500-crore-in-india-for-making-oral-weight-loss-drug\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/trak.in\/stories\/wp-content\/uploads\/2025\/10\/Screenshot-2025-10-07-at-9.11.06-AM.png\",\"datePublished\":\"2025-10-07T03:43:24+00:00\",\"dateModified\":\"2025-10-07T03:43:57+00:00\",\"author\":{\"@id\":\"https:\/\/trak.in\/stories\/#\/schema\/person\/5092a7d2906e3f3c819643435477c2a7\"},\"breadcrumb\":{\"@id\":\"https:\/\/trak.in\/stories\/pharma-giant-to-invest-rs-8500-crore-in-india-for-making-oral-weight-loss-drug\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/trak.in\/stories\/pharma-giant-to-invest-rs-8500-crore-in-india-for-making-oral-weight-loss-drug\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/trak.in\/stories\/pharma-giant-to-invest-rs-8500-crore-in-india-for-making-oral-weight-loss-drug\/#primaryimage\",\"url\":\"https:\/\/trak.in\/stories\/wp-content\/uploads\/2025\/10\/Screenshot-2025-10-07-at-9.11.06-AM.png\",\"contentUrl\":\"https:\/\/trak.in\/stories\/wp-content\/uploads\/2025\/10\/Screenshot-2025-10-07-at-9.11.06-AM.png\",\"width\":2358,\"height\":1410},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/trak.in\/stories\/pharma-giant-to-invest-rs-8500-crore-in-india-for-making-oral-weight-loss-drug\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/trak.in\/stories\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Pharma Giant To Invest Rs 8500 Crore In India For Making Oral Weight Loss Drug\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/trak.in\/stories\/#website\",\"url\":\"https:\/\/trak.in\/stories\/\",\"name\":\"Trak.in - Indian Business of Tech, Mobile & Startups\",\"description\":\"Trak.in is a popular Indian Business, Technology, Mobile & Startup blog featuring trending News, views and analytical take on Technology, Business, Finance, Telecom, Mobile, startups & Social Media Space\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/trak.in\/stories\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/trak.in\/stories\/#\/schema\/person\/5092a7d2906e3f3c819643435477c2a7\",\"name\":\"Mohul Ghosh\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\/\/trak.in\/stories\/#\/schema\/person\/image\/\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/66c129d83dd3f325a3b550eb1aa16891173ddfc4686361424206cd9a01311c89?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/66c129d83dd3f325a3b550eb1aa16891173ddfc4686361424206cd9a01311c89?s=96&d=mm&r=g\",\"caption\":\"Mohul Ghosh\"},\"url\":\"https:\/\/trak.in\/stories\/author\/mohul-ghosh\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Pharma Giant To Invest Rs 8500 Crore In India For Making Oral Weight Loss Drug - Trak.in - Indian Business of Tech, Mobile & Startups","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/trak.in\/stories\/pharma-giant-to-invest-rs-8500-crore-in-india-for-making-oral-weight-loss-drug\/","og_locale":"en_US","og_type":"article","og_title":"Pharma Giant To Invest Rs 8500 Crore In India For Making Oral Weight Loss Drug - Trak.in - Indian Business of Tech, Mobile & Startups","og_description":"US pharmaceutical giant Eli Lilly is set to significantly expand its presence in India through a series of strategic initiatives, reinforcing the country as a key hub in its global operations. The company announced plans to invest over $1 billion in the coming years to bolster contract manufacturing partnerships, enhance global supply chains, and increase […]","og_url":"https:\/\/trak.in\/stories\/pharma-giant-to-invest-rs-8500-crore-in-india-for-making-oral-weight-loss-drug\/","og_site_name":"Trak.in - Indian Business of Tech, Mobile & Startups","article_published_time":"2025-10-07T03:43:24+00:00","article_modified_time":"2025-10-07T03:43:57+00:00","og_image":[{"width":1024,"height":612,"url":"https:\/\/trak.in\/stories\/wp-content\/uploads\/2025\/10\/Screenshot-2025-10-07-at-9.11.06-AM-1024x612.png","type":"image\/png"}],"author":"Mohul Ghosh","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Mohul Ghosh","Est. reading time":"3 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/trak.in\/stories\/pharma-giant-to-invest-rs-8500-crore-in-india-for-making-oral-weight-loss-drug\/","url":"https:\/\/trak.in\/stories\/pharma-giant-to-invest-rs-8500-crore-in-india-for-making-oral-weight-loss-drug\/","name":"Pharma Giant To Invest Rs 8500 Crore In India For Making Oral Weight Loss Drug - Trak.in - Indian Business of Tech, Mobile & Startups","isPartOf":{"@id":"https:\/\/trak.in\/stories\/#website"},"primaryImageOfPage":{"@id":"https:\/\/trak.in\/stories\/pharma-giant-to-invest-rs-8500-crore-in-india-for-making-oral-weight-loss-drug\/#primaryimage"},"image":{"@id":"https:\/\/trak.in\/stories\/pharma-giant-to-invest-rs-8500-crore-in-india-for-making-oral-weight-loss-drug\/#primaryimage"},"thumbnailUrl":"https:\/\/trak.in\/stories\/wp-content\/uploads\/2025\/10\/Screenshot-2025-10-07-at-9.11.06-AM.png","datePublished":"2025-10-07T03:43:24+00:00","dateModified":"2025-10-07T03:43:57+00:00","author":{"@id":"https:\/\/trak.in\/stories\/#\/schema\/person\/5092a7d2906e3f3c819643435477c2a7"},"breadcrumb":{"@id":"https:\/\/trak.in\/stories\/pharma-giant-to-invest-rs-8500-crore-in-india-for-making-oral-weight-loss-drug\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/trak.in\/stories\/pharma-giant-to-invest-rs-8500-crore-in-india-for-making-oral-weight-loss-drug\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/trak.in\/stories\/pharma-giant-to-invest-rs-8500-crore-in-india-for-making-oral-weight-loss-drug\/#primaryimage","url":"https:\/\/trak.in\/stories\/wp-content\/uploads\/2025\/10\/Screenshot-2025-10-07-at-9.11.06-AM.png","contentUrl":"https:\/\/trak.in\/stories\/wp-content\/uploads\/2025\/10\/Screenshot-2025-10-07-at-9.11.06-AM.png","width":2358,"height":1410},{"@type":"BreadcrumbList","@id":"https:\/\/trak.in\/stories\/pharma-giant-to-invest-rs-8500-crore-in-india-for-making-oral-weight-loss-drug\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/trak.in\/stories\/"},{"@type":"ListItem","position":2,"name":"Pharma Giant To Invest Rs 8500 Crore In India For Making Oral Weight Loss Drug"}]},{"@type":"WebSite","@id":"https:\/\/trak.in\/stories\/#website","url":"https:\/\/trak.in\/stories\/","name":"Trak.in - Indian Business of Tech, Mobile & Startups","description":"Trak.in is a popular Indian Business, Technology, Mobile & Startup blog featuring trending News, views and analytical take on Technology, Business, Finance, Telecom, Mobile, startups & Social Media Space","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/trak.in\/stories\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Person","@id":"https:\/\/trak.in\/stories\/#\/schema\/person\/5092a7d2906e3f3c819643435477c2a7","name":"Mohul Ghosh","image":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/trak.in\/stories\/#\/schema\/person\/image\/","url":"https:\/\/secure.gravatar.com\/avatar\/66c129d83dd3f325a3b550eb1aa16891173ddfc4686361424206cd9a01311c89?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/66c129d83dd3f325a3b550eb1aa16891173ddfc4686361424206cd9a01311c89?s=96&d=mm&r=g","caption":"Mohul Ghosh"},"url":"https:\/\/trak.in\/stories\/author\/mohul-ghosh\/"}]}},"jetpack_featured_media_url":"https:\/\/trak.in\/stories\/wp-content\/uploads\/2025\/10\/Screenshot-2025-10-07-at-9.11.06-AM.png","jetpack_sharing_enabled":true,"_links":{"self":[{"href":"https:\/\/trak.in\/stories\/wp-json\/wp\/v2\/posts\/1301134","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/trak.in\/stories\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/trak.in\/stories\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/trak.in\/stories\/wp-json\/wp\/v2\/users\/30"}],"replies":[{"embeddable":true,"href":"https:\/\/trak.in\/stories\/wp-json\/wp\/v2\/comments?post=1301134"}],"version-history":[{"count":1,"href":"https:\/\/trak.in\/stories\/wp-json\/wp\/v2\/posts\/1301134\/revisions"}],"predecessor-version":[{"id":1301143,"href":"https:\/\/trak.in\/stories\/wp-json\/wp\/v2\/posts\/1301134\/revisions\/1301143"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/trak.in\/stories\/wp-json\/wp\/v2\/media\/1301142"}],"wp:attachment":[{"href":"https:\/\/trak.in\/stories\/wp-json\/wp\/v2\/media?parent=1301134"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/trak.in\/stories\/wp-json\/wp\/v2\/categories?post=1301134"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/trak.in\/stories\/wp-json\/wp\/v2\/tags?post=1301134"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}